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Abstract 25 
A binary mosquitocidal toxin composed of a three-domain Cry-like toxin (Cry48Aa) and a 26 
binary-like toxin (Cry49Aa) was identified in Lysinibacillus sphaericus. Cry48Aa/Cry49Aa has 27 
action on Culex quinquefasciatus larvae, in particular, to those that are resistant to the Bin Binary 28 
toxin, which is the major insecticidal factor from L. sphaericus-based biolarvicides, indicating 29 
that Cry48Aa/Cry49Aa interacts with distinct target sites in the midgut and can overcome Bin 30 
toxin resistance. This study aimed to identify Cry48Aa/Cry49Aa ligands in C. quinquefasciatus 31 
midgut through binding assays and mass spectrometry. Several proteins, mostly from 50 to 120 32 
kDa, bound to the Cry48Aa/Cry49Aa toxin were revealed by toxin overlay and pull-down 33 
assays. These proteins were identified against the C. quinquefasciatus genome and after analysis 34 
a set of 49 proteins were selected which includes midgut bound proteins such as 35 
aminopeptidases, amylases, alkaline phosphatases in addition to molecules from other classes 36 
that can be potentially involved in this toxin’s mode of action. Among these, some proteins are 37 
orthologs of Cry receptors previously identified in mosquito larvae, as candidate receptors for 38 
Cry48Aa/Cry49Aa toxin. Further investigation is needed to evaluate the specificity of their 39 
interactions and their possible role as receptors. 40 
 41 
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 43 
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1. Introduction 48 
Lysinibacillus sphaericus is an entomopathogen that can produce crystals containing protoxins 49 
with high and selective activity against mosquito larvae, in particular those from the Culex 50 
pipiens complex. Some insecticidal proteins have been identified in L. sphaericus strains (Allievi 51 
et al., 2014; Berry, 2012) and the Binary crystal protoxin (Bin), which was the first 52 
mosquitocidal factor characterized, remains the active principle of the commercial larvicides 53 
based on this bacterium (Silva Filha et al., 2014). Bin is a heterodimer composed of BinA (42 54 
kDa) and BinB (51 kDa) polypeptides which are produced at high levels in equimolar 55 
concentrations by some strains (Charles et al., 1996). Bin achieves the optimal activity only 56 
when both components are present, which characterizes its binary nature (Nicolas et al., 1993). 57 
Its mode of action has been mostly studied in species from the Culex pipiens complex and, after 58 
ingestion and proteolytic processing of protoxins, the active BinB subunit is responsible for 59 
specifically binding to the Cpm1/Cqm1 α-glucosidases that act as midgut receptors (Darboux et 60 
al., 2001; Romão et al., 2006; Silva-Filha et al., 1999), while the BinA component is associated 61 
with cell toxicity (Nicolas et al., 1993). Resistance of C. pipiens and C. quinquefasciatus larvae 62 
to Bin toxin has been recorded (Mulla et al., 2003; Nielsen-Leroux et al., 2002; Rao et al., 1995; 63 
Wirth et al., 2000; Yuan et al., 2000) due to mutations in genes encoding the receptors, which 64 
lead to the production of truncated or non-functional proteins and cause the failure of Bin toxin 65 
binding on the midgut epithelium. This has been the major resistance mechanism documented 66 
and cqm1/cpm1 alleles causing such failures have been reported (Chalegre et al., 2012; Chalegre 67 
et al., 2015; Darboux et al., 2007; Darboux et al., 2002; Guo et al., 2013; Romão et al., 2006). 68 
 Resistance to L. sphaericus based on loss of Bin toxin binding highlights the need to 69 
characterize molecules with distinct modes of action. Investigation of L. sphaericus strain IAB59 70 
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began soon after the first reports of Bin-based resistance since this strain is toxic to Bin-resistant 71 
larvae, suggesting the production of a novel insecticidal factor that can overcome resistance to 72 
Bin toxin (Nielsen-LeRoux et al., 2001; Pei et al., 2002; Yuan et al., 2003). Jones et al. (2007) 73 
identified the insecticidal factor as Cry48Aa (135 kDa) and Cry49Aa (53 kDa), which are also 74 
produced as protoxins in small crystalline inclusions during sporulation. Cry48Aa/Cry49Aa is 75 
considered a new binary toxin produced by L. sphaericus since neither the Cry48Aa nor 76 
Cry49Aa component shows toxicity to larvae alone (Jones et al., 2007). They can act in synergy 77 
forming the complex Cry48Aa/Cry49Aa through the N-terminal portion of the Cry49Aa subunit 78 
(Guo et al., 2016). These toxins have comparable toxicity to Bin against C. quinquefasciatus, and 79 
remain active to Bin-resistant larvae, when both Cry toxins are produced as recombinant proteins 80 
and are administered in equimolar ratios (Jones et al., 2008). Unfortunately, native strains are 81 
deficient in expression of Cry48Aa and do not attain the optimal 1:1 Cry48:Cry49 ratio required 82 
for high toxicity, which accounts for why strains such as IAB59 can produce both binary toxins, 83 
but are not more toxic than strains producing only Bin toxin. 84 
 The Cry48Aa component of the toxin belongs to the three-domain (3D) structural 85 
family of Cry proteins with 33% amino acid identity with the Cry4Aa toxin from Bacillus 86 
thuringiensis svar. israelensis (Bti) (Boonserm et al., 2006; Jones et al., 2007). Cry49Aa is part 87 
of the group Bin-toxin-like proteins (Toxin–10 family) with about 30% identity to both subunits 88 
of the Bin toxin from L. sphaericus, in addition to comparable identity to Cry36 (34%) and 89 
Cry35 (20%) produced by B. thuringiensis strains (Berry, 2012; Jones et al., 2007). The initial 90 
steps of the mode of action of Cry48Aa and Cry49Aa are similar to that of the Bin toxin 91 
comprising ingestion of crystals, solubilization under alkaline pH and proteolytic activation of 92 
protoxins into toxins (Jones et al., 2008), interaction with midgut (de Melo et al., 2009; Guo et 93 
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al., 2016) followed by cytopathological effects which appear similar to those produced by a 94 
synergistic mixture of Cry-like and Bin-like toxins (de Melo et al., 2009). However, the identity 95 
of ligands and receptors in the larval midgut that underlie toxic action and larval mortality is still 96 
unknown. The investigation of this specific step of the mode of action is strategic since 97 
Cry48Aa/Cry49Aa is toxic to Bin-resistant C. quinquefasciatus lacking the midgut receptors 98 
(Cqm1) for Bin toxin (de Melo et al., 2009; Pei et al., 2002) which indicates that the 99 
Cry48/Cry49 toxin complex interacts with distinct molecules mediating toxicity to larvae. 100 
Recently it was shown that both subunits display the ability to bind to the C. quinquefasciatus 101 
larval midgut (Guo et al., 2016). In this context, the major goal of the present study was to 102 
identify potential ligands for Cry48Aa/Cry49Aa in the midgut of C. quinquefasciatus larvae and 103 
contribute to the understanding of the mode of action of this mosquitocidal toxin. 104 
 105 
2. Materials and methods  106 
2.1 Preparation of Cry toxins 107 
Cry48Aa and Cry49Aa were produced individually in the acrystalliferous Bacillus thuringiensis 108 
svar. israelensis strain 4Q7 transformed with plasmids pSTAB135 and pHTP49, which carry 109 
genes encoding the respective toxins (Jones et al., 2007). Cultures were grown in sporulation 110 
medium (de Barjac and Lecadet, 1976) supplemented with 1% glucose and erythromycin (25 111 
µg/ml), under agitation (200 rpm) at 30°C, for 72 h until reaching sporulation (≥80%). Spore-112 
crystal biomass was centrifuged, sequentially washed with 1M NaCl/10 mM EDTA pH 8.0 and 113 
10 mM EDTA pH 8.0, and stored at -80°C. Crystal/spores from both recombinant Bt strains 114 
were also processed together. For this purpose biomass containing spore-crystals of each 115 
protein were combined (1:1 wt/wt), solubilized (50 mM NaOH, 30°C, 1 h, at 150 rpm), the 116 
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supernatant containing both solubilized proteins was separated by centrifugation (21.000g, 117 
4°C, 30 min) and the pH was adjusted to ≈8.5 using 0.1 M HCl. Combined protoxins were 118 
activated with pancreatic bovine trypsin (1:100 wt/wt, 30°C, 1 h). Supernatant, containing 119 
the activated proteins, was centrifuged as described above and then dialyzed (0.02 M 120 
sodium phosphate, pH 8, 4°C, 16 h). Protein concentration was determined according to 121 
Bradford (1976) using the Biorad reagent (Biorad, Hercules, CA, USA) and a bovine serum 122 
albumin standard curve. Size and the integrity of proteins were analyzed in 10% SDS-123 
PAGE. Activated proteins were stored at -80°C. Moreover, in this study Cry49Aa protein 124 
fused to a C-terminal poly-histidine tag (Cry49Aa-His) was individually produced in Escherichia 125 
coli T7 express cells (New England Biolabs, Beverly, Ma, USA). For this purpose, the cry49Aa 126 
gene was amplified from pHTP49 (described above) using specific primers containing BamHI 127 
(bold) and NotI (underlined) restriction sites (Fwd 5’-128 
CGAGGATCCATGGAAAATCAAATAAAAGAAGAATTTAAC-3’, Rev 5’-129 
CGAGCGGCCGCATTATAATATGGCTTTGAATTTTCATG-3’) and subsequently cloned into 130 
the expression vector pET21a® (Novagen, USA). Antibodies against the His-tag were used to 131 
track binding of the Cry48Aa/Cry49Aa mix through the Cry49-His. Attempts to produce 132 
Cry48Aa in E. coli in order to have a suitable expression to evaluate this toxin were not 133 
successful. For Cry49Aa cultures of transformed T7 express cells were grown using Luria-134 
Bertani (LB) medium supplemented with ampicillin (100 µg/ml) (under agitation, 200 rpm, 37°C 135 
until reaching an OD600 of 0.5), and induced with IPTG (0.1 mM, 30°C, 4 h). Cultures were 136 
centrifuged (21.500g, 4°C, 10 min), the cell pellets were re-suspended in phosphate-buffered 137 
saline pH 7.4 (PBS), sonicated, and Triton X-100 was added to a final 1% vol/vol. The samples 138 
were centrifuged (1700g, 30 min, 4°C) and proteins from the supernatants were purified using 139 
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the Ni-NTA resin (Qiagen, Hilden, Germany), according to the manufacturer’s instructions. 140 
Proteins were eluted with 1M imidazole in wash buffer (50 mM sodium phosphate-buffer, 300 141 
mM NaCl, 10% glycerol, pH 6, 4°C, 1 h) and dialyzed (50 mM dibasic sodium phosphate, 5 mM 142 
monobasic sodium phosphate, 50 mM NaCl, 0.1% Triton x-100, 5% glycerol, pH 7.8, 4°C, 143 
overnight). Protein integrity and concentration were verified, as previously described. The 144 
purified Cry49Aa-His from E. coli was combined with solubilized Cry48Aa from Bt in 1:2 ratio 145 
(µg protein: µg protein) and the mixed sample was subjected to in vitro processing, as previously 146 
described. The concentration and integrity of the activated mix of proteins was verified by 10% 147 
SDS-PAGE and then it was stored at -80°C. Cry49Aa fused to glutathione S-transferase 148 
(Cry49Aa-GST) was also individually produced in E. coli BL21 Star™ (DE3) cells 149 
(ThermoFischer Scientific, Waltham, MA, USA). cry49Aa gene was amplified from 150 
pHTP49 using the following primers containing BamHI and NotI  sites as described (Fwd 151 
5’-CGAGGATCCATGGAAAATCAAATAAAAGAAGAATTTAAC-3’, Rev 5’- 152 
CGAGCGGCCGCTTAATTATAATATGGCTTTGAATTTTCATG -3’). The BinB subunit of 153 
the binary toxin fused to glutathione S-transferase (BinB-GST) was also produced 154 
according to Romão et al. (2006). Further steps to produce both purified GST proteins are 155 
also described in that study. 156 
 157 
2.2 Mosquito strain 158 
Fourth instar larvae of the CqSLab Culex quinquefasciatus strain were used in this study. This 159 
colony has been maintained in the insectarium of the Instituto Aggeu Magalhães/FIOCRUZ for 160 
more than five years under controlled conditions of 26 ±1°C, 70% relative humidity, and a 161 
12h:12h (light/dark) photoperiod. CqSLab is a laboratory reference colony susceptible to 162 
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insecticidal compounds. Larvae were reared in dechlorinated water and fed on cat food. Adults 163 
were maintained on a 10% sugar solution, and females were also artificially fed with rabbit 164 
blood. 165 
 166 
2.3 Midgut brush border membrane fractions  167 
Midgut apical membrane enriched preparations, called brush border membrane fractions 168 
(BBMFs), were prepared with batches of whole frozen (-80°C) 4th instar larvae (5 g) as described 169 
by (Silva-Filha et al., 1997). BBMFs were solubilized with 1% CHAPS (3-[(3-cholamidopropyl) 170 
dimethylammonio]-2-hydroxy-1-propanesulfonate) according to Silva-Filha et al. (1999). BBMF 171 
and CHAPS-solubilized proteins (CHAPS-extract) were stored at -80°C. Protein concentration 172 
was determined as described in section 2.1 and the enrichment of proteins from apical cell 173 
membranes was evaluated through the detection of D-glucosidase activity (EC 3.2.1.20), 174 
according to Ferreira et al. (2014).  175 
 176 
2.4 Homologous competition binding assays 177 
Competition assays were performed to evaluate the capacity of radiolabeled (125I) 178 
individual Cry48Aa, Cry49Aa and a mixture of these toxins to bind to BBMF, according to 179 
Silva-Filha et al. (1997). Labeled individual toxins or a mixture of Cry48Aa/Cry49Aa (1:1) 180 
(10 nM) were incubated with BBMF proteins (25 µg) in the absence, or in the presence of 181 
increasing concentrations (3, 10, 30, 100, 300, 1000, 3000 nM), of each homologous 182 
unlabeled toxin used as competitor, for 16 h at room temperature (RT). After incubation, 183 
125I-toxins bound to BBMF were separated through centrifugation (21,000g, 15 min, 4 °C), 184 
sediments were rinsed twice with PBS, added to a scintillation cocktail and analyzed using 185 
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a scintillation beta counter. Each experimental point was repeated at least four times and 186 
the inhibitory concentration of the competitor that reduces the binding response by half 187 
(IC50) was determined using GraphPad Prism™ software (GraphPad, La Jolla, CA, USA). 188 
 189 
2.5 Toxin overlay assays 190 
As an initial approach to identify the C. quinquefasciatus midgut proteins that bind to 191 
Cry48Aa/Cry49Aa-His toxin, proteins (30-40 µg) from BBMF and CHAPS-extracts were 192 
separated on 10% SDS-PAGE and transferred to nitrocellulose Protran® membranes (GE 193 
Healthcare, Germany). Membranes were first incubated in TBS-T buffer (20 mM Tris-HCl pH 194 
7.6, 150 mM NaCl, 0.05% Tween 20), containing 5% nonfat dry milk at RT for 1h and then with 195 
a mix (100 µg) of Cry48Aa/Cry49Aa-His activated toxins (16 h at 4°C). Unbound toxins were 196 
removed by washing with TBS-T buffer (4x 15 min at RT). Membranes were then incubated 197 
with a primary monoclonal serum raised against poly-histidine (Sigma-Aldrich, St Louis, MO, 198 
USA) (1:5.000, 1 h at RT) followed by washings and incubation with the secondary serum raised 199 
against mouse IgG conjugated to horseradish peroxidase (1:10.000, 1 h at RT). After washing, 200 
membranes were subjected to chemiluminescence detection using Luminata Forte® (Millipore, 201 
Billerica, MA, USA) to detect binding of the Cry48Aa/Cry49Aa mix through the Cry49-His 202 
bound to midgut proteins. Similar membranes with midgut proteins, but without incubation 203 
with the Cry48Aa/Cry49a-His mix, were subjected to immunodetection and were used as 204 
negative controls. Assays were conducted in triplicate.  205 
 206 
2.6 Pull-down assays 207 
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Protein–protein binding assays were also performed using a mix of Cry48Aa/Cry49Aa activated 208 
toxins immobilized on CNBr activated sepharose 4B® (GE Healthcare, Uppsala, Sweden) beads 209 
adapted from the protocol described by Zhou et al. (2016). Briefly, activated Cry48Aa/Cry49Aa 210 
mix (1 mg) was immobilized on beads (500 μL), for 16h at 4°C. After washings (0.2 M NaHCO3 211 
pH 8.3) potential remaining active groups on the resin were blocked (glycine 0.1 M pH 8, 6h at 212 
RT) and the coupled Cry48Aa/Cry49Aa beads were re-suspended in a final volume of 500 μL of 213 
phosphate-buffered saline (pH 7.4) and stored at 4°C. Pull-down assays were then conducted 214 
using Cry48Aa/Cry49Aa beads (50 μL) and CHAPS-extracts (50 μg) incubated for 2 h at 4°C. 215 
After incubation, unbound proteins were removed by centrifugation (400g, 30 s, 4°C) and beads 216 
were washed five times with 500 μL of phosphate-buffered saline pH 7.4/ 1 M NaCl, followed 217 
by five washes with 500 μL of phosphate-buffered saline pH 7.4. Proteins that remained bound 218 
to the Cry48Aa/Cry49Aa beads were solubilized in Laemmli buffer boiled for 10 min and 219 
visualized in 10% SDS-PAGE. Samples of CNBr sepharose beads coupled with 0.1 M Tris-HCl 220 
buffer (pH 8.5) were submitted to pull-down assays with CHAPS-extracts and used as negative 221 
controls. Gels were stained with Coomassie blue or PlusOne Silver Staining kit® (GE 222 
Healthcare). At least three gels for each staining were analyzed.  223 
A second set of pull-down assays was conducted using recombinant Cry49Aa and BinB 224 
toxins produced by E. coli fused to glutathione S-transferase (GST) and immobilized on 225 
glutathione-sepharose 4B™ beads (GE Healthcare, Uppsala, Sweden), according to Romão 226 
et al. (2006). For the assays the Cry49Aa-GST beads were pre-incubated with activated 227 
recombinant Cry48Aa toxin from Bt for 1 h at RT. After this, Cry49Aa-GST beads were 228 
recovered by centrifugation (1.500 g, 2 min, 4ºC) and washed three times with BB3 buffer 229 
(100 mM KCl /1 mM MgCl2/50 mM HEPES/0.2% Nonidet P-40/5% glycerol). Sf9 cell 230 
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culture medium samples enriched with Cqm1 recombinant protein were obtained as 231 
described in Ferreira et al. (2014) and Cqm1 content in samples was estimated based on a 232 
standard curve of purified Cqm1 protein immunodetected with an antibody raised against 233 
Cqm1 (Romão et al., 2006). Medium samples containing Cqm1 protein (0.015-1.5 µg) were 234 
incubated with equivalent amounts (~10 µg) of BinB beads, or Cry49Aa beads, or GST 235 
beads (negative control) for 2 h, at RT in BB3 buffer. After incubation beads samples, 236 
washed and recovered as described above, were separated on 10% SDS-PAGE, transferred 237 
to nitrocellulose membranes and subjected to immunoblotting with the antibody anti 238 
Cqm1.  239 
 240 
2.7 Mass spectrometry analysis 241 
Protein samples from a silver stained gel were sectioned into eight parts according to the 242 
molecular weight range and sent for LC-MS/MS analysis in the Proteomics and Mass 243 
Spectrometry Facility (PAMS) from the University of Georgia. In-gel digestions of these bands 244 
were performed. The tryptic peptides were analyzed by an Orbitrap Elite mass spectrometer 245 
coupling with a Proxeon nanoLC system (Thermo Scientific, Waltham, MA, USA). The data-246 
dependent acquisition (DDA) Top 8 method was used to acquire MS data. Protein identification 247 
and characterization of modifications were performed using Thermo Proteome Discoverer 248 
(version 1.4) with Mascot (Matrix Science, London, UK). The NCBI proteome reference 249 
database for C. quinquefasciatus was downloaded on October 10, 2016. The searched protein 250 
database was complete, but redundant; the 39,875 entry database was composed of 18,883 251 
entries from the NCBI reference protein database for C. quinquefasciatus and Refseq, UniProt 252 
and EMBL C. quinquefasciatus protein entries.  253 
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 254 
3. Results 255 
3.1 Production of Cry toxins 256 
Crystal/spore samples produced individually in the recombinant Bt strains were the sources of 257 
Cry49Aa (≈53 kDa) and Cry48Aa (≈135 kDa), yielding protoxins with their expected molecular 258 
weights (Fig. 1A, lanes 1 and 3). In vitro processing of Cry49Aa protoxin produced a major 259 
polypeptide of ≈44 kDa while Cry48Aa processing resulted in fragments of ≈68 and 46 kDa 260 
(Fig. 1A, lanes 2 and 4). Crystal/spores from both recombinant Bt strains were also processed 261 
together, as described in section 2.1, and the mix of activated proteins showed a similar 262 
activation pattern to that of the individually processed toxins (Fig. 1A, lane 5). The mix of 263 
activated Cry48Aa/Cry49Aa toxins was employed for pull-down assays, based on the 264 
results of competition binding assays described below in section 3.2. Cry49Aa protoxin 265 
containing a poly-histidine tag (Cry49Aa-His) was also produced in E. coli as a recombinant 266 
protein of ≈53 kDa (Fig. 1B, lane 1). A mix of protoxins produced in Bt and E. coli 267 
(Cry48Aa/Cry49Aa-His) respectively, (Fig. 1B lane 2) processed in vitro exhibited the pattern 268 
(Fig. 1B, lane 3) (Cry48Aa, ≈68 and 46 kDa; Cry49Aa ≈44 kDa) as observed before (Fig. 1A, 269 
lane 5). Similarly, this Cry48Aa/Cry49Aa-His mixture of activated toxins was employed to 270 
perform overlay assays. Cry49Aa-GST and BinB-GST were successfully produced and 271 
showed a expected molecular of around 80 kDa (data not shown). 272 
 273 
3.2 Cry toxins binding to midgut proteins  274 
BBMFs used in assays showed a protein concentration of 5.1±0.8 µg/µl and the enrichment of ɑ-275 
glucosidase activity in the BBMF, compared to the initial whole larvae extract used, was 3.3±0.9 276 
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fold. First, homologous competition assays were performed to evaluate the binding capacity 277 
of Cry48Aa and Cry49Aa toxins to C. quinquefasciatus midgut brush border proteins 278 
(BBMF). Individual labelled toxins and the mixture of labeled Cry48Aa/Cry49Aa bound 279 
specifically to BBMF and were displaced in presence of the respective unlabeled 280 
homologous competitors (Fig. S1). Labeled Cry48Aa/Cry49Aa showed a lower IC50 (41 281 
nM), compared to those observed for Cry48Aa (83 nM) and Cry49Aa (95 nM) individual 282 
labeled toxins (Fig. S1), indicating that the binding affinity of the Cry48Aa/Cry49Aa mix to 283 
C. quinquefasciatus BBMF is higher than the individual toxins.  284 
The binding ability of the activated Cry48Aa/Cry49Aa-His mixture to the C. 285 
quinquefasciatus BBMF proteins was investigated through overlay assays. Cry48Aa/Cry49Aa-286 
His mix recognized midgut proteins of about 52, 58, 65, 73, 80, 90, 100-125 kDa, based on the 287 
immunodetection of bound Cry49Aa-His toxin (Fig. 2A, lanes 1, 3). Most of the proteins 288 
observed in these BBMF samples were also detected in solubilized midgut proteins (CHAPS-289 
extract) (Fig. 2A, lanes 2, 4). Cry49Aa-His, included among the SDS-PAGE samples as positive 290 
control, was recognized by the monoclonal antibody raised against the poly-histidine tail of this 291 
protein (Fig. 2A, lane 5). In parallel the immunodetection of midgut proteins without incubation 292 
with the Cry48Aa/Cry49Aa-His mix, was used as a negative control. In this assay two major 293 
proteins (≈44 and 48 kDa) from BBMF and CHAPS-extract (Fig. 2B, lanes 1-4) were recognized 294 
by the anti-His antibody and they were discarded from further analysis as potential binding 295 
proteins as well as proteins whose molecular weights were lower than 40-50 kDa since they 296 
seemed to be a result of non-specific binding, as observed on negative control blot overlays. 297 
 298 
3.3 Identification of Cry48Aa/Cry49Aa binding proteins   299 
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A proteomic approach was performed to identify Cry48Aa/Cry49Aa binding proteins from C. 300 
quinquefasciatus solubilized BBMF proteins. Pull-down assays were performed between midgut 301 
CHAPS-solubilized proteins (Fig. 3, lane 1) and activated Cry48Aa/Cry49Aa toxins immobilized 302 
on CNBr-beads (Fig. 3, lane 2). Pulled-down, i.e. extracted proteins were separated by 10% 303 
SDS-PAGE and then visualized by silver staining. Separation of proteins from the 304 
Cry48Aa/Cry49Aa beads alone (not incubated with gut extracts) showed major bands of ≈ 68, 46 305 
and 44 kDa, a profile similar to the activated Cry48Aa/Cry49Aa toxins (Fig. 1A, lane 5). A band 306 
of ≈ 90 kDa is possibly a Cry49Aa dimer that is stable under the conditions of this assay. Midgut 307 
proteins that bound to the immobilized toxins (Fig. 3, lane 3) showed apparent molecular weights 308 
consistent with those immunodetected as potential ligands in the overlay assays (Fig. 2A, lanes 309 
1-4). When midgut solubilized proteins were incubated with CNBr beads that had been prepared 310 
by incubation with Tris buffer only (without Cry48Aa/Cry49Aa), used as a negative control, no 311 
proteins bound to the beads were visualized by silver staining (data not shown). Lane 3 from the 312 
pull-down assay (Fig. 3) was cut into eight sections that were subjected to LC-MS/MS analysis. 313 
A list of 266 C. quinquefasciatus proteins from gel sections (1-8) with a significance score 314 
higher than 67 and the number of unique peptides greater than 2 as threshold, is presented in the 315 
supplementary table 1 (Table S1). From this dataset a group of 49 proteins was selected (Table 316 
1), in most cases, because they belong to a class previously reported as Cry receptors/ligands, or 317 
they were already cited as molecules potentially involved in the mode of action of those toxins. 318 
Proteins that were detected in more than one gel section were cited in that section corresponding 319 
to its expected molecular weight (Table 1). When a protein occurred in sections where the 320 
molecular weight range differs from the predicted weight, they were cited in the section where 321 
they displayed the highest scores. Gel section 8 (30-45 kDa) displayed the highest number of 322 
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identified proteins and this is likely to be related to the presence of polypeptides resulting from 323 
the degradation of higher molecular weight proteins. Several selected proteins from Table 1 324 
belong to protein classes that have been described as functional receptors to 3-domain Cry 325 
toxins, including aminopeptidases (APN), maltases and alkaline phosphatases (ALPs). Eight of 326 
these proteins are orthologs of functional receptors for Cry toxins from B. thuringiensis svar. 327 
israelensis or B. thuringiensis svar. jegathesan previously identified in Aedes aegypti or 328 
Anopheles gambiae larvae (Table 2). These proteins have molecular weights that were consistent 329 
with those of the bands detected in the binding assays. APN molecules were detected in all 330 
sections analysed regardless of the fact that their predicted molecular weights are greater than 331 
100 kDa. Maltases including α-glucosidases also were found in almost all sections and the C. 332 
quinquefasciatus maltase 1 (Cqm1), the receptor of the Bin toxin, was detected in sections 5 and 333 
6. ALPs, on the other hand, were exclusively detected in section 5. Proteins already described as 334 
ligands to Cry toxins as apolipophorin, actin, dipeptidyl-peptidase, glyceraldehyde-3-phosphate 335 
dehydrogenase, glucosil transferase, myosin-Id, prohibitin, ATP synthase (alpha or beta subunit), 336 
and V-ATP synthase (subunit E or H) were found with high score in one or more sections 337 
analyzed. In addition, proteins not previously characterized as Cry binding proteins were 338 
identified such as aldehyde dehydrogenase, calcium-transporting ATPase 339 
sarcoplasmic/endoplasmic reticulum type, carboxylesterase-6, carboxypeptidase A1, fasciclin, 340 
maltose phosphorylase, panthetheinase, sodium-potassium-transporting ATPase alpha chain, 341 
sodium-potassium-dependent ATPase beta-2 subunit, transferrin, truncated ER mannose-binding 342 
lectin, and vanin-like protein 1.  343 
The identification of Cqm1 among the ligands led to the investigation of its role in 344 
the mode of action of Cry48Aa/Cry49Aa since this toxin is active against L. sphaericus 345 
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resistant larvae due to the loss of Cqm1 (de Melo et al., 2009). Pull-down assays between 346 
recombinant Cqm1 protein and Cry49Aa-GST immobilized on sepharose beads previously 347 
pre-incubated with Cry48Aa, was compared with the respective assay between Cqm1 and 348 
the BinB subunit. Cqm1 bound to BinB-GST, as expected, while Cqm1 bound to Cry49Aa-349 
GST but binding was only detected using Cqm1 amounts about 30-fold higher, compared 350 
to that used to detect binding to BinB (Fig. S2). 351 
 352 
4. Discussion 353 
Three-domain Cry toxins might require midgut processing for their insecticidal activity and Bin 354 
protoxins are also converted in this way (Berry, 2012; Tabashnik et al., 2015). In this study a 355 
mixture of Cry48Aa and Cry49Aa protoxins processed in vitro yielded a pattern of activated 356 
toxins similar to that observed for individually processed toxins (Jones et al., 2008). These 357 
activated individual subunits showed the capacity to bind to C. quinquefasciatus midgut, in 358 
agreement with Guo et al. (2016). The IC50 values determined in our work were higher but 359 
it is likely that differences in the methodology, biotinylated Cry toxins and fresh BBMF 360 
employed by Guo et al. (2016), might have improved the resolution of these binding assays. 361 
On the other hand our study showed that the Cry48Aa/Cry49Aa mixture bound with 362 
higher affinity than the individual subunits and this indicated that both Cry48Aa and 363 
Cry49Aa toxins are required to attain maximal binding affinity to C. quinquefasciatus 364 
midgut, in contrast to Bin binary toxin whose binding ability relies exclusively on the BinB 365 
subunit (Charles et al., 1997). Cry48Aa/Cry49Aa interacts with larval midgut and our study 366 
shows a set of C. quinquefasciatus proteins that bound to Cry48Aa/Cry49Aa toxin using overlay 367 
and pull-down assays. Although our study showed midgut ligands when both Cry48Aa/Cry49Aa 368 
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toxins were employed in the assays, the role of each toxin for this interaction requires further 369 
investigation.  370 
Cry48Aa/Cry49Aa ligands identified in this study include molecules belonging to protein 371 
classes previously characterized as receptors of other Cry toxins, plus other proteins that may be 372 
potentially involved in the mode of action. Several forms of APNs/metalloproteases were 373 
detected as ligands, which is consistent with previous studies that have demonstrated that APNs 374 
act as Cry toxin receptors. In mosquito larvae, for instance, APNs were identified as Cry11Ba, 375 
Cry11Aa and Cry4Ba receptors in Anopheles quadrimaculatus (Abdullah et al., 2006), An. 376 
gambiae (Zhang et al., 2008) and Aedes aegypti (Aroonkesorn et al., 2015; Chen et al., 2009; 377 
Chen et al., 2013). The apparent sizes of several identified APNs suggested proteolytic 378 
degradation and/or formation of dimers with high-molecular weight. Some of these C. 379 
quinquefasciatus APNs are orthologs, with more than 60% identity, to known Cry receptors cited 380 
above, which reinforces their possible role as Cry48Aa/Cry49Aa receptors. Maltases, including 381 
α-glucosidases and α-amylases, although less numerous than APNs, were also identified and 382 
proteins from this class have been reported as receptors for Cry11Aa and Cry4Ba toxins in An. 383 
albimanus (Fernandez-Luna et al., 2010) and Cry11Ba toxin in An. gambiae (Zhang et al., 2013). 384 
Ortholog α-glucosidases Cpm1 and Cqm1 are proven, and Agm3 is a putative receptor of Bin 385 
toxin in C. pipiens, C. quinquefasciatus and An. gambiae, respectively (Darboux et al., 2001; 386 
Opota et al., 2008; Romão et al., 2006). Agm3 was also reported as a receptor to Cry11Ba toxin 387 
in An. gambiae (Zhang et al., 2013) and Cqm1, the Bin receptor in C. quinquefasciatus, was 388 
identified among the Cry48Aa/Cry49Aa ligands in this study. Cry48Aa/Cry49Aa is active 389 
against Bin-resistant larvae deprived of the Cqm1 α-glucosidase and this finding might indicate 390 
that Cry48Aa/Cry49Aa binding to Cqm1 is not specific or that the toxin can bind alternative 391 
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receptors without dependence on Cqm1. Comparative binding assays performed in this study 392 
confirmed that Cqm1 binding to Cry48Aa/Cry49Aa is much more limited than that 393 
observed to the BinB subunit from the Bin toxin. In contrast to APNs and maltases, only three 394 
alkaline phosphatases (ALPs) were detected exclusively in gel section 5 (50-62 kDa) and one of 395 
them is an ortholog of an Ae. aegypti ALP which is a binding protein for Cry4Ba (Bayyareddy et 396 
al., 2009). ALPs have been identified as receptors for Cry11Aa and Cry4Ba in Ae. aegypti 397 
(Dechklar et al., 2011; Fernández et al., 2006) and Cry11Ba in An. gambiae (Hua et al., 2009). 398 
Cadherins play a major role for the binding and oligomerization of some 3-domain Cry toxins 399 
(Bravo et al., 2004) but they were not identified in this study. This could be due the low 400 
abundance of cadherins in mosquito midgut and their relative instability in brush border 401 
preparations. Whether or not cadherins have a role in Cry48/49 action merits more attention.  402 
Some proteins identified in our study were shown to be associated with lipid rafts that are 403 
enriched in glycosphingolipids, cholesterol and GPI-anchored proteins; functionally they are 404 
proposed to be involved in signal transduction, sorting and trafficking of proteins and pathogens 405 
(Bayyareddy et al., 2012). Among them apolipophorin, identified in this study, was previously 406 
found as a ligand for the Cry8Ea toxin (Shu et al., 2015), glucosyl transferase was identified as 407 
binding protein for Cry1Aa (Zhou et al., 2016), prohibitin was detected as ligand for Cry4Ba and 408 
Cry3Aa ( Kuadkitkan et al., 2012; Ochoa-Campuzano et al., 2013). Other proteins associated 409 
with lipid rafts of Ae. aegypti were identified in our study including calcium-transporting 410 
ATPase sarcoplasmic/endoplasmic reticulum type, carboxylesterase-6, fasciclin, maltose 411 
phosphorylase and transferrin, however, their functional relevance to the Cry toxin mode of 412 
action is unknown (Bayyareddy et al., 2012). Vanin-like protein 1 and pantetheinase are 413 
members of the Vanin family that can be expressed as membrane-associated proteins (Pitari et 414 
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al., 2000). Vanin-1 proteins, as well as aldehyde dehydrogenases, are associated with lipid rafts 415 
in Ae. aegypti and although their function has been scarcely studied, it could be related to the 416 
regulation of responses to oxidative stress, detoxification processes and recycling (Bayyareddy et 417 
al., 2012; Pitari et al., 2000; Popova-Butler and Dean, 2009).  418 
Several proteins identified as integral membrane components according to their Gene 419 
Ontology (GO) classifications were extracted by Cry48Aa/49Aa beads including sodium-420 
potassium-transporting ATPase alpha chain, sodium-potassium-dependent ATPase beta-2 421 
subunit, and truncated ER mannose-binding lectin. Dipeptidyl-peptidase, a membrane 422 
component found in our study, was already identified as a Cry1Aa ligand (Zhou et al., 2016). 423 
Consistent with other studies that detected intracellular proteins forming part of the cell 424 
cytoskeleton as Cry toxin ligands, some, such as actin, myosin and glyceraldehyde-3-phosphate 425 
dehydrogenase (Bayyareddy et al., 2009; Chen et al., 2010; Krishnamoorthy et al., 2007; Shu et 426 
al., 2015; Zhou et al., 2016), were also found in this investigation. However, further studies 427 
remain to be performed to understand the function of these proteins in Cry48Aa/Cry49Aa mode 428 
of action. Among the mitochondrial proteins detected in our study the most relevant were V-429 
ATPases, as they have been identified as Cry toxin binding proteins in different insects, although 430 
their localization on the cytoplasmic side of the plasma membrane seems inconsistent with a 431 
direct receptor function (Bayyareddy et al., 2009; Chen et al., 2010; Krishnamoorthy et al., 432 
2007). Detection of the α- and β-ATP synthases is also consistent with the literature as they are 433 
reported as Cry4Ba and Cry1Ac toxin ligands (Bayyareddy et al., 2009; Zhou et al., 2016). 434 
However, the ATP synthase complex is related with ATP generation in mitochondrial membrane 435 
and their presence has been considered as evidence of contamination in midgut preparations. 436 
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 This study reveals a set of ligands of the Cry48Aa/Cry49Aa toxin in C. quinquefasciatus 437 
that are described as molecules involved in the mode of action of Cry toxins in different target 438 
insects. Some of them were identified as toxin ligands in binding assays and it is possible that 439 
they could be involved in the intracellular mode of action of Cry toxins rather than being 440 
membrane receptors. Molecules such as APNs, ALPS and maltases have been characterized as 441 
toxin receptors based on their localization as membrane-bound proteins and their capacity to 442 
bind specifically to the toxins with high affinity, as monomers or oligomers, in order to display 443 
toxicity in insect midguts. This study provides evidence of binding ligands for 444 
Cry48Aa/Cry49Aa toxin in C. quinquefasciatus midgut and further work is necessary to 445 
elucidate their role on its mode of action since the unique composition of Cry48Aa/Cry49Aa, 446 
consisting of a 3D-Cry like and Bin-like subunits, could display distinct features compared to 447 
models already described for toxins from these groups. 448 
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Supplementary data 460 
Table S1. Complete data set of Culex quinquefasciatus midgut proteins found as ligands of 461 
Cry48Aa/Cry49Aa toxin through pull-down assays and identification by mass spectrometry.  462 
 463 
Figure S1. Homologous competition binding assays between labeled (125I-) Cry48Aa, 464 
Cry49Aa, or a mixture of both toxins (10 nM) with midgut brush border membrane 465 
fractions (25 Pg) from Culex quinquefasciatus larvae in the absence, or in the presence, of 466 
respective unlabeled toxins (3-3000 nM). Maximum binding corresponds to the binding 467 
observed in the absence of competitor. The competitor concentration that displaces 50% of 468 
the 125I-bound toxin (IC50) is indicated. Each point is the mean of, at least, four 469 
experimental replicates.  470 
 471 
Figure S2. Pull-down assay to evaluate the binding of the recombinant Cqm1 protein to the 472 
recombinant Cry48Aa/Cry49Aa-GST toxin (A) , BinB-GST toxin (B) or GST (C, negative 473 
control) immobilized on sepharose beads. After incubation, beads were washed and bound 474 
proteins were separated on 10% SDS-PAGE, transferred to nitrocellulose membranes and 475 
subjected to immunodetection with an antibody raised against Cqm1 protein. P. Cqm1 476 
protein (0.15 µg). MW molecular weight in kDa. 477 
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FIGURE LEGENDS 659 
 660 
Fig. 1. Cry48Aa and Cry49Aa recombinant proteins separated in 10% SDS-PAGE and 661 
visualized with Coomassie blue. A. Proteins expressed in Bacillus thuringiensis svar. israelensis 662 
4Q7 strain, Cry49Aa solubilized (1) and activated (2), Cry48Aa solubilized (3) and activated (4), 663 
mixture of Cry48Aa/Cry49Aa activated together (5). B. Cry49Aa-His produced in Escherichia 664 
coli (1), mix of protoxins Cry48Aa/Cry49Aa-His (2), mix Cry48Aa/Cry49Aa-His activated 665 
together (3). MW molecular weight in kDa. * protoxins and their activated forms. 666 
 667 
Fig. 2. Overlay assays performed between Culex quinquefasciatus midgut proteins and 668 
Cry48Aa/Cry49Aa-His. Midgut proteins from BBMV (30-40 µg, lanes 1, 3) and after 669 
solubilization with CHAPS (30-40 µg, lanes 2, 4) were separated on 10% SDS-PAGE, 670 
transferred to a nitrocellulose membrane, incubated with activated Cry48Aa/Cry49Aa-His (2 µg) 671 
(A) or without toxin (B) and subjected to immunodetection with a monoclonal anti-poly-histidine 672 
antibody to detect bound Cry49-His. Sample of Cry49-His protein (lane 5). MW molecular 673 
weight in kDa. Major proteins detected (*) and those (º) observed in negative control (B). 674 
 675 
Fig. 3. Proteins identified by pull-down assay. Pull-down assays were performed between 676 
solubilized Culex quinquefasciatus migdut proteins (A) and a mix of activated 677 
Cry48Aa/Cry49Aa toxins immobilized on CNBr-beads (B) and resulting bound proteins to toxin 678 
beads (C). Samples were separated in 10% SDS-PAGE and silver stained. MW molecular weight 679 
in kDa. The eight sections from lane 3 were subjected to mass spectrometry. Cry49Aa putative 680 
dimer (*). 681 
1 
 Table 1. Selected Culex quinquefasciatus m
idgut proteins detected as ligands of C
ry48A
a/C
ry49A
a toxin through pull-dow
n assays 
1 
and identification by LC
-M
S/M
S. 
2 
Section  
A
ccession no.  
D
escription  
Score  
C
overage 
(%
)  
N
o. unique 
peptides  
Predicted 
M
W
 (kD
a)  
D
etection 
sections  
1 (110-180 kD
a)  
ED
S27419.1
a 
protease m
1 zinc m
etalloprotease  
365.96 
18.00 
9 
113.2 
2,3,4,5,7,8 
 
ED
S27892.1 
calcium
-transporting A
TPase sarcoplasm
ic/ER
 type  146.88 
7.74 
4 
88.8 
2,4 
2 (90-110 kD
a)  
ED
S27418.1
a 
protease m
1 zinc m
etalloprotease  
93.25 
11.25 
6 
101.2 
 
 
ED
S40798.1 
C
H
P
 c 
78.46 
2.96 
2 
100.1 
 
 
ED
S36841.1
a 
am
inopeptidase N
  
74.67 
8.38 
3 
105.0 
 
3 (70-90 kD
a)  
ED
S38951.1
a 
alpha-glucosidase 
619.19 
40.83 
25 
69.4 
4,5,6,8 
 
ED
S30018.1 
apolipophorins 
374.88 
6.41 
18 
366.8 
4,5 
 
ED
S38952.1 
alpha-glucosidase 
374.85 
25.37 
12 
70.6 
4,5 
 
ED
S32575.1 
m
altose phosphorylase 
277.49 
18.29 
10 
85.4 
 
 
ED
S45210.1 
dipeptidyl peptidase 4 
250.82 
19.19 
12 
84.1 
 
 
ED
S32578.1 
m
altose phosphorylase 
206.18 
15.58 
11 
85.1 
 
 
ED
S32127.1 
alpha-glucosidase 
199.35 
20.66 
10 
70.7 
 
 
ED
S32576.1 
m
altose phosphorylase 
172.15 
7.89 
5 
84.8 
 
 
ED
S26147.1 
sodium
/potassium
-transporting A
TPase alpha chain 
97.64 
5.44 
3 
80.3 
5,6,7,8 
 
ED
S35643.1 
glutam
yl am
inopeptidase 
93.53 
6.02 
5 
116.5 
 
Table 1
2 
  
ED
S37148.1 
dipeptidyl-peptidase 
88.24 
6.05 
5 
88.2 
2 
4 (62-70 kD
a)  
ED
S38950.1
a 
m
altase 1  
183.05 
11.26 
6 
69.4 
5 
 
ED
S45922.1 
pantetheinase  
113.26 
16.47 
9 
57.1 
 
5 (50-62 kD
a)  
ED
S35272.1 
C
H
P
 c: A
TP synthase subunit alpha 
1914.86 
59.17 
40 
59.3 
6,8 
 
ED
S27254.1 
A
TP synthase beta subunit  
1100.18 
56.16 
21 
54.6 
2,6,8 
 
ED
S29323.1 
alkaline phosphatase  
563.81 
27.30 
14 
62.9 
 
 
A
B
C
59609.1
b 
m
altase 1 (C
qm
1)  
528.27 
29.31 
18 
66.2 
6 
 
ED
S39442.1 
V
-type A
TP synthase beta chain  
515.83 
38.82 
15 
54.7 
8 
 
ED
S29322.1
a 
alkaline phosphatase  
485.67 
17.04 
13 
100.6 
 
 
ED
S29972.1 
A
TP synthase alpha subunit vacuolar  
474.63 
31.76 
15 
68.1 
3,4,5,6,8 
 
ED
S27420.1
a 
protease m
1 zinc m
etalloprotease  
215.56 
8.23 
6 
102.7 
4 
 
ED
S35286.1 
C
H
P: A
ldehyde dehydrogenase 
200.25 
12.86 
2 
58.1 
 
 
ED
S29320.1 
alkaline phosphatase  
186.96 
15.91 
5 
28.9 
 
 
ED
S45921.1 
V
anin-like protein 1  
166.86 
7.21 
4 
61.6 
 
 
ED
S28386.1 
transferrin  
158.64 
15.15 
5 
51.4 
4 
 
ED
S42579.1 
glucosyl transferase  
98.98 
6.01 
3 
58.2 
 
 
ED
S44961.1 
m
yosin-Id 
113.40 
3.18 
2 
77.9 
6 
 
ED
S31007.1 
am
inopeptidase N
  
68.48 
4.43 
4 
105.4 
 
6 (48-50 kD
a)  
ED
S31006.1
 a 
am
inopeptidase N
  
984.52 
13.66 
23 
210.0 
2,3,5,8 
 
ED
S27170.1 
truncated ER
 m
annose-binding lectin 
279.17 
18.26 
8 
53.4 
5,7,8 
3 
  
ED
S35706.1 
vacuolar A
TP synthase subunit H
  
243.87 
15.19 
6 
54.5 
8 
7 (45-48 kD
a)  
ED
S44431.1 
fasciclin 
71.84 
7.08 
2 
48.4 
 
8 (30-45 kD
a)  
ED
S26297.1 
C
a-transporting A
TPase sarcoplasm
ic/ER
 type 
2335.41 
32.46 
4 
109.1 
3,5,6 
 
ED
S44094.1 
actin 1  
1699.07 
48.94 
3 
41.7 
 
 
ED
S25844.1 
actin-2  
1689.34 
47.61 
6 
41.6 
3,5 
 
ED
S38275.1 
C
H
P
 c 
755.20 
34.77 
10 
33.0 
3,5 
 
ED
S28370.1 
N
a/K
-dependent A
TPase beta-2 subunit  
602.81 
34.05 
10 
37.9 
 
 
ED
S28367.1 
N
a/K
-dependent A
TPase beta-2 subunit  
521.83 
35.65 
10 
36.2 
 
 
ED
S36304.1 
N
a/K
-dependent A
TPase beta-2 subunit  
447.15 
24.66 
7 
33.4 
 
 
ED
S29666.1 
vacuolar A
TP synthase subunit e  
389.43 
27.88 
7 
25.8 
 
 
ED
S45475.1 
C
H
P: G
lyceraldehyde-3-phosphate dehydrogenase 
225.43 
20.78 
6 
35.4 
 
 
ED
S28502.1 
carboxylesterase-6 
177.38 
5.06 
3 
71.1 
6 
 
ED
S26618.1 
prohibitin-2  
164.97 
15.38 
5 
33.1 
 
 
ED
S34662.1 
carboxypeptidase A
1 
96.08 
9.18 
3 
48.4 
 
a O
rthologs identified in Aedes aegypti or Anopheles species know
n as functional receptors to C
ry toxins, details are show
n in Table 2. 
3 
b Culex quinquefasciatus m
altase 1 (C
qm
1) receptor of the B
inary toxin. 
4 
c C
H
P:C
onserved hypothetical protein. 
5 
 
6 
1 
 Table 2. Culex quinquefasciatus m
idgut proteins identified as potential ligands of C
ry48A
a/C
ry49A
a toxins and their orthologs in 
1 
Aedes aegypti or Anopheles species that w
ere described as receptors of other D
iptera-active C
ry toxins. 
2 
A
ccession 
no. 
D
escription 
O
rthologs id 
Identity 
(%
) 
Specie 
Toxin 
R
eference 
ED
S31006.1  am
inopeptidase N
 
A
A
EL008155 
31.4 
Ae. aegypti 
C
ry11A
a 
(C
hen et al., 2013) 
ED
S36841.1  am
inopeptidase N
 
A
A
EL005808 
63.6 
Ae. aegypti 
C
ry4B
a 
(Saengw
im
an et al., 2011) 
ED
S27418.1 
protease m
1 zinc m
etalloprotease 
A
A
EL012783 
70.9 
Ae. aegypti 
C
ry4B
a 
ED
S27419.1  protease m
1 zinc m
etalloprotease 
A
A
EL012778 
65.1 
Ae. aegypti 
C
ry11A
a 
C
ry4B
a 
(C
hen et al., 2009b) 
(Saengw
im
an et al., 2011) 
ED
S27420.1 
protease m
1 zinc m
etalloprotease 
A
A
EL012776 
63.4 
Ae. aegypti 
C
ry4B
a 
(B
ayyareddy et al., 2009) 
ED
S38951.1  alpha-glucosidase 
A
A
LB
015771 
A
G
A
P008963 
64.3 
64.9 
An. albimanus 
An. gambiae 
C
ry11A
a 
C
ry11B
a 
(Fernandez-Luna et al., 2010) 
(Zhang et al., 2013) 
ED
S38950.1  m
altase 1 
A
A
LB
015771 
A
G
A
P008963 
61.3 
62.8 
An. albimanus 
An. gambiae 
C
ry11A
a 
C
ry11B
a 
(Fernandez-Luna et al., 2010) 
(Zhang et al., 2013) 
ED
S29322.1  alkaline phosphatase 
A
A
EL003313 
67.1 
Ae. aegypti 
C
ry4B
a 
(B
ayyareddy et al., 2009) 
 
3 
 
4 
Table 2
Supplementary Fig. 1. C
om
plete data set of Culex quinquefasciatus m
idgut proteins found as ligands of C
ry48A
a/C
ry49A
a toxin through 
pull-dow
n assays and identification by m
ass spectrom
etry.  
 Section A
ccession N
° D
escription 
Score 
C
overage 
(%
) 
N
° U
nique 
Peptides 
N
° A
A
s 
Predicted M
W
 
[kD
a] 
 pI 
1 
ED
S27419.1 
protease m
1 zinc m
etalloprotease  
365.96 
18.00 
9 
1011 
113.2 
5.12 
 
ED
S27892.1 
calcium
-transporting A
TPase sarcoplasm
ic/endoplasm
ic reticulum
 type  146.88 
7.74 
4 
814 
88.8 
6.00 
2 
ED
S31006.1 
am
inopeptidase N
  
316.58 
14.69 
13 
1852 
210.0 
5.08 
 
ED
S27419.1 
protease m
1 zinc m
etalloprotease  
271.97 
14.05 
8 
1011 
113.2 
5.12 
 
ED
S27892.1 
calcium
-transporting A
TPase sarcoplasm
ic/endoplasm
ic reticulum
 type  144.70 
13.27 
5 
814 
88.8 
6.00 
 
ED
S27418.1 
protease m
1 zinc m
etalloprotease  
93.25 
11.25 
6 
898 
101.2 
5.14 
 
ED
S37148.1 
dipeptidyl-peptidase  
90.93 
10.09 
4 
793 
88.2 
6.47 
 
ED
S40798.1 
conserved hypothetical protein  
78.46 
2.96 
2 
911 
100.1 
7.30 
 
ED
S41405.1 
angiotensin-converting enzym
e  
78.22 
3.09 
2 
1229 
142.8 
5.22 
 
ED
S27254.1 
A
TP synthase beta subunit  
77.51 
8.22 
2 
511 
54.6 
5.12 
 
ED
S36841.1 
am
inopeptidase N
  
74.67 
8.38 
3 
919 
105.0 
5.01 
3 
ED
S29972.1 
A
TP synthase alpha subunit vacuolar  
744.99 
51.63 
23 
614 
68.1 
5.39 
 
ED
S27419.1 
protease m
1 zinc m
etalloprotease  
632.33 
26.51 
20 
1011 
113.2 
5.12 
 
ED
S38951.1 
alpha-glucosidase  
619.19 
40.83 
25 
605 
69.4 
5.20 
 
ED
S39731.1 
78 kD
a glucose-regulated protein  
415.13 
28.31 
16 
657 
72.3 
5.20 
 
ED
S30018.1 
apolipophorins  
374.88 
6.41 
18 
3324 
366.8 
7.36 
 
ED
S38952.1 
alpha-glucosidase  
374.85 
25.37 
12 
611 
70.6 
5.31 
 
ED
S35981.1 
endoplasm
in  
354.28 
25.69 
20 
794 
91.0 
4.98 
Table supplem
entary 1
 
ED
S26297.1 
calcium
-transporting atpase sarcoplasm
ic/endoplasm
ic reticulum
 type  346.17 
14.97 
13 
995 
109.1 
5.59 
 
ED
S34040.1 
fatty acid oxidation com
plex subunit alpha  
329.63 
27.69 
19 
744 
79.7 
9.06 
 
ED
S35048.1 
conserved hypothetical protein  
308.85 
27.29 
14 
645 
71.4 
6.86 
 
ED
S26512.1 
succinate dehydrogenase flavoprotein subunit. m
itochondrial  
278.70 
19.21 
9 
661 
72.1 
6.46 
 
ED
S32575.1 
m
altose phosphorylase  
277.49 
18.29 
10 
760 
85.4 
5.78 
 
ED
S31006.1 
am
inopeptidase N
  
258.73 
6.26 
10 
1852 
210.0 
5.08 
 
ED
S45210.1 
dipeptidyl peptidase 4  
250.82 
19.19 
12 
745 
84.1 
5.01 
 
ED
S32578.1 
m
altose phosphorylase  
206.18 
15.58 
11 
764 
85.1 
5.67 
 
ED
S32127.1 
alpha-glucosidase  
199.35 
20.66 
10 
610 
70.7 
4.92 
 
ED
S32576.1 
m
altose phosphorylase  
172.15 
7.89 
5 
760 
84.8 
6.37 
 
ED
S32138.1 
heat shock 70 kD
a protein cognate 4  
140.16 
9.16 
3 
655 
71.4 
5.52 
 
ED
S42649.1 
long-chain-fatty-acid coa ligase  
139.79 
10.06 
6 
696 
78.0 
8.18 
 
ED
S39919.1 
disulfide isom
erase  
135.33 
11.16 
5 
493 
55.4 
4.91 
 
ED
S33460.1 
carnitine O
-palm
itoyltransferase 2. m
itochondrial  
132.79 
14.92 
9 
657 
74.5 
7.97 
 
ED
S42654.1 
5' nucleotidase  
120.83 
11.54 
5 
546 
59.9 
4.84 
 
ED
S39080.1 
beta-galactosidase  
112.60 
9.69 
6 
650 
73.7 
4.89 
 
ED
S36767.1 
C
D
98hc am
ino acid transporter protein  
112.54 
6.73 
4 
639 
70.2 
5.08 
 
ED
S25844.1 
actin-2  
106.42 
18.09 
3 
376 
41.6 
5.48 
 
ED
S40938.1 
integrin alpha-ps  
103.28 
4.86 
4 
1112 
124.5 
5.53 
 
ED
S38275.1 
conserved hypothetical protein  
100.53 
17.22 
4 
302 
33.0 
9.72 
 
ED
S26147.1 
sodium
/potassium
-transporting A
TPase alpha chain  
97.64 
5.44 
3 
735 
80.3 
5.67 
 
ED
S26794.1 
conserved hypothetical protein  
94.97 
3.06 
7 
2324 
249.4 
4.96 
 
ED
S35643.1 
glutam
yl am
inopeptidase  
93.53 
6.02 
5 
1030 
116.5 
6.25 
 
ED
S37148.1 
dipeptidyl-peptidase  
88.24 
6.05 
5 
793 
88.2 
6.47 
 
ED
S31874.1 
neurotactin  
84.61 
5.83 
4 
857 
94.2 
5.01 
 
ED
S35272.1 
conserved hypothetical protein  
76.96 
8.53 
4 
551 
59.3 
8.94 
 
ED
S36798.1 
long-chain-fatty-acid coa ligase  
76.18 
6.47 
4 
649 
72.3 
7.93 
 
ED
S28166.1 
elongation factor 2  
72.03 
4.07 
4 
1031 
114.4 
6.71 
 
ED
S31200.1 
nodal m
odulator 3  
70.21 
2.88 
2 
868 
93.8 
6.54 
4 
ED
S38950.1 
m
altase 1  
382.03 
37.42 
20 
604 
69.4 
4.94 
 
ED
S27892.1 
calcium
-transporting A
TPase sarcoplasm
ic/endoplasm
ic reticulum
 type  206.55 
13.76 
10 
814 
88.8 
6.00 
 
ED
S28386.1 
transferrin  
176.12 
21.21 
8 
462 
51.4 
6.67 
 
ED
S38952.1 
alpha-glucosidase  
156.43 
27.00 
14 
611 
70.6 
5.31 
 
ED
S25721.1 
electron transfer flavoprotein-ubiquinone oxidoreductase  
139.13 
16.31 
9 
607 
66.1 
6.54 
 
ED
S36767.1 
C
D
98hc am
ino acid transporter protein  
132.75 
11.42 
7 
639 
70.2 
5.08 
 
ED
S39919.1 
disulfide isom
erase  
129.60 
8.72 
4 
493 
55.4 
4.91 
 
ED
S38951.1 
alpha-glucosidase  
121.82 
11.90 
7 
605 
69.4 
5.20 
 
ED
S45922.1 
pantetheinase  
113.26 
16.47 
9 
516 
57.1 
5.39 
 
ED
S27419.1 
protease m
1 zinc m
etalloprotease  
101.76 
4.45 
4 
1011 
113.2 
5.12 
 
ED
S27420.1 
protease m
1 zinc m
etalloprotease  
99.42 
9.34 
7 
899 
102.7 
5.59 
 
ED
S29972.1 
A
TP synthase alpha subunit vacuolar  
91.37 
11.40 
5 
614 
68.1 
5.39 
 
ED
S42654.1 
5' nucleotidase  
82.25 
8.97 
5 
546 
59.9 
4.84 
 
ED
S30018.1 
apolipophorins  
78.86 
1.11 
3 
3324 
366.8 
7.36 
5 
ED
S35272.1 
conserved hypothetical protein - A
TP synthase subunit alpha 
1914.86 
59.17 
40 
551 
59.3 
8.94 
 
ED
S27254.1 
A
TP synthase beta subunit  
1100.18 
56.16 
21 
511 
54.6 
5.12 
 
B
A
I77924.1 
cytochrom
e P450  
923.53 
48.39 
24 
496 
56.3 
7.69 
 
ED
S31872.1 
lactase-phlorizin hydrolase  
779.33 
44.92 
22 
532 
61.4 
5.20 
 
ED
S26297.1 
calcium
-transporting atpase sarcoplasm
ic/endoplasm
ic reticulum
 type  660.27 
22.61 
2 
995 
109.1 
5.59 
 
ED
S27419.1 
protease m
1 zinc m
etalloprotease  
596.77 
20.57 
17 
1011 
113.2 
5.12 
 
ED
S29323.1 
alkaline phosphatase  
563.81 
27.30 
14 
564 
62.9 
5.01 
 
A
B
C
59609.1 m
altase 1  
528.27 
29.31 
18 
580 
66.2 
5.95 
 
ED
S39442.1 
V
-type A
TP synthase beta chain  
515.83 
38.82 
15 
492 
54.7 
5.49 
 
ED
S29322.1 
alkaline phosphatase  
485.67 
17.04 
13 
904 
100.6 
5.63 
 
ED
S36767.1 
C
D
98hc am
ino acid transporter protein  
485.29 
25.20 
17 
639 
70.2 
5.08 
 
ED
S29972.1 
A
TP synthase alpha subunit vacuolar  
474.63 
31.76 
15 
614 
68.1 
5.39 
 
ED
S31870.1 
lactase-phlorizin hydrolase  
453.52 
19.35 
11 
920 
105.6 
5.27 
 
ED
S35287.1 
conserved hypothetical protein  
416.13 
26.74 
8 
460 
51.2 
7.08 
 
ED
S37279.1 
croquem
ort  
375.07 
24.31 
10 
469 
52.6 
4.67 
 
ED
S42910.1 
disulfide isom
erase  
347.91 
35.54 
14 
484 
53.8 
6.25 
 
ED
S38951.1 
alpha-glucosidase  
339.73 
20.83 
12 
605 
69.4 
5.20 
 
ED
S25844.1 
actin-2  
313.78 
37.77 
4 
376 
41.6 
5.48 
 
ED
S45363.1 
cytochrom
e P450  
310.42 
30.46 
16 
522 
58.6 
7.15 
 
ED
S36420.1 
cytochrom
e p450 fam
ily protein 44A
1  
286.50 
27.05 
13 
499 
57.6 
8.62 
 
ED
S34125.1 
conserved hypothetical protein  
271.63 
31.91 
2 
376 
41.8 
5.48 
 
ED
S38514.1 
sarcalum
enin  
248.99 
8.66 
7 
958 
107.6 
3.93 
 
ED
S31006.1 
am
inopeptidase N
  
241.43 
5.62 
9 
1852 
210.0 
5.08 
 
ED
S35981.1 
endoplasm
in  
235.94 
14.99 
10 
794 
91.0 
4.98 
 
ED
S27504.1 
5' nucleotidase  
219.42 
18.77 
9 
554 
60.8 
5.53 
 
ED
S27420.1 
protease m
1 zinc m
etalloprotease  
215.56 
8.23 
6 
899 
102.7 
5.59 
 
ED
S27170.1 
truncated ER
 m
annose-binding lectin  
213.76 
13.59 
6 
471 
53.4 
6.05 
 
ED
S36419.1 
cytochrom
e P450 26B
1  
211.90 
12.83 
6 
499 
57.1 
8.37 
 
ED
S26147.1 
sodium
/potassium
-transporting A
TPase alpha chain  
209.18 
9.52 
6 
735 
80.3 
5.67 
 
ED
S35286.1 
conserved hypothetical protein  
200.25 
12.86 
2 
521 
58.1 
7.97 
 
ED
S38952.1 
alpha-glucosidase  
195.21 
11.95 
6 
611 
70.6 
5.31 
 
ED
S41433.1 
conserved hypothetical protein  
188.63 
30.43 
3 
115 
13.3 
9.25 
 
ED
S28872.1 
disulfide-isom
erase A
6  
187.22 
19.95 
7 
436 
47.5 
5.49 
 
ED
S29320.1 
alkaline phosphatase  
186.96 
15.91 
5 
264 
28.9 
9.32 
 
ED
S38275.1 
conserved hypothetical protein  
185.09 
20.86 
6 
302 
33.0 
9.72 
 
ED
S38950.1 
m
altase 1  
183.05 
11.26 
6 
604 
69.4 
4.94 
 
ED
S38022.1 
chitotriosidase-1  
178.22 
17.27 
7 
440 
48.6 
6.81 
 
ED
S34537.1 
cytochrom
e P450 12b1. m
itochondrial  
177.44 
8.19 
4 
525 
60.0 
7.74 
 
ED
S45921.1 
V
anin-like protein 1  
166.86 
7.21 
4 
555 
61.6 
5.14 
 
B
A
K
26813.1 cytochrom
e P450  
164.41 
13.41 
7 
537 
61.4 
7.55 
 
ED
S28166.1 
elongation factor 2  
163.42 
5.43 
5 
1031 
114.4 
6.71 
 
ED
S28386.1 
transferrin  
158.64 
15.15 
5 
462 
51.4 
6.67 
 
ED
S32421.1 
calnexin  
158.29 
13.41 
7 
589 
66.6 
4.65 
 
ED
S34510.1 
cytochrom
e P450 9b2  
157.50 
11.42 
5 
534 
61.3 
7.90 
 
ED
S40900.1 
saccharopine dehydrogenase dom
ain-containing protein  
156.83 
11.63 
5 
430 
47.7 
8.47 
 
ED
S32097.1 
prolylcarboxypeptidase  
150.43 
9.38 
3 
501 
57.5 
4.83 
 
ED
S38838.1 
glutactin  
150.03 
10.70 
5 
570 
63.2 
5.94 
 
ED
S44930.1 
l(2) long form
  
148.82 
4.95 
5 
1294 
148.8 
4.58 
 
ED
S32098.1 
prolylcarboxypeptidase  
144.01 
15.29 
6 
726 
84.5 
4.61 
 
ED
S25721.1 
electron transfer flavoprotein-ubiquinone oxidoreductase  
141.98 
6.75 
4 
607 
66.1 
6.54 
 
ED
S27857.1 
U
D
P-glucuronosyltransferase 2B
4  
141.38 
10.56 
4 
521 
59.0 
7.62 
 
A
EN
19673.1 cytochrom
e P405 C
Y
P9J40  
136.89 
15.46 
5 
524 
59.8 
8.50 
 
ED
S28616.1 
catalase  
134.43 
12.04 
5 
490 
55.0 
7.43 
 
ED
S37300.1 
olygosaccharyltransferase alpha subunit  
128.00 
10.46 
5 
459 
51.8 
8.22 
 
B
0W
Y
Y
2.1 
R
ecN
am
e: Full=M
oesin/ezrin/radixin hom
olog 1 
123.67 
9.62 
6 
572 
67.7 
5.68 
 
ED
S26512.1 
succinate dehydrogenase flavoprotein subunit. m
itochondrial  
122.42 
6.05 
3 
661 
72.1 
6.46 
 
ED
S45144.1 
dolichyl-diphosphooligosaccharide protein glycotransferase  
118.05 
5.08 
2 
453 
49.5 
5.71 
 
B
A
I77921.1 
cytochrom
e P450  
116.88 
13.41 
6 
507 
57.4 
8.46 
 
ED
S44961.1 
m
yosin-Id  
113.40 
3.18 
2 
692 
77.9 
9.14 
 
B
A
I77925.1 
cytochrom
e P450  
112.08 
7.30 
4 
493 
57.3 
8.12 
 
ED
S26138.1 
cytochrom
e P450  
109.67 
6.79 
2 
501 
57.3 
7.53 
 
ED
S43476.1 
glycogen phosphorylase  
106.39 
2.73 
2 
842 
96.6 
6.37 
 
ED
S30018.1 
apolipophorins  
105.93 
0.72 
2 
3324 
366.8 
7.36 
 
ED
S27182.1 
prolylcarboxypeptidase  
104.81 
8.79 
4 
512 
58.3 
4.56 
 
ED
S41432.1 
conserved hypothetical protein  
100.23 
7.54 
2 
305 
34.6 
7.14 
 
ED
S42579.1 
glucosyl transferase  
98.98 
6.01 
3 
516 
58.2 
7.69 
 
ED
S34040.1 
fatty acid oxidation com
plex subunit alpha  
97.04 
6.45 
4 
744 
79.7 
9.06 
 
ED
S35048.1 
conserved hypothetical protein  
90.01 
8.99 
5 
645 
71.4 
6.86 
 
ED
S31797.1 
synaptotagm
in  
85.68 
3.64 
3 
825 
89.9 
6.35 
 
ED
S30010.1 
conserved hypothetical protein  
77.74 
2.04 
2 
931 
103.5 
5.02 
 
ED
S41303.1 
24-dehydrocholesterol reductase  
72.17 
3.57 
2 
504 
58.4 
8.38 
 
ED
S34513.1 
cytochrom
e P450 9b2  
71.72 
3.33 
2 
540 
61.8 
6.49 
 
ED
S43339.1 
brain chitinase and chia  
70.89 
9.48 
5 
485 
53.5 
5.34 
 
ED
S31007.1 
am
inopeptidase N
  
68.48 
4.43 
4 
926 
105.4 
6.19 
6 
ED
S31006.1 
am
inopeptidase N
  
984.52 
13.66 
23 
1852 
210.0 
5.08 
 
ED
S35272.1 
conserved hypothetical protein  - A
TP synthase subunit alpha 
613.20 
32.30 
16 
551 
59.3 
8.94 
 
ED
S27254.1 
A
TP synthase beta subunit  
546.45 
33.07 
13 
511 
54.6 
5.12 
 
ED
S26297.1 
calcium
-transporting atpase sarcoplasm
ic/endoplasm
ic reticulum
 type  380.57 
13.67 
2 
995 
109.1 
5.59 
 
ED
S38798.1 
m
itochondrial processing peptidase beta subunit  
352.77 
20.25 
10 
474 
52.2 
6.13 
 
ED
S27170.1 
truncated ER
 m
annose-binding lectin  
279.17 
18.26 
8 
471 
53.4 
6.05 
 
ED
S35706.1 
vacuolar A
TP synthase subunit H
  
243.87 
15.19 
6 
474 
54.5 
6.14 
 
ED
S34125.1 
conserved hypothetical protein  
211.62 
31.65 
3 
376 
41.8 
5.48 
 
ED
S37675.1 
conserved hypothetical protein  
210.59 
11.50 
7 
887 
98.8 
5.76 
 
ED
S36615.1 
adipocyte plasm
a m
em
brane-associated protein  
182.45 
8.56 
6 
841 
92.2 
8.06 
 
ED
S28872.1 
disulfide-isom
erase A
6  
178.50 
15.14 
6 
436 
47.5 
5.49 
 
ED
S26631.1 
juvenile horm
one epoxide hydrolase 1  
126.90 
9.52 
5 
462 
53.0 
6.92 
 
ED
S38951.1 
alpha-glucosidase  
121.02 
7.77 
4 
605 
69.4 
5.20 
 
ED
S45881.1 
gam
m
a glutam
yl transpeptidase  
118.93 
4.49 
2 
579 
62.2 
5.20 
 
ED
S26147.1 
sodium
/potassium
-transporting A
TPase alpha chain  
117.12 
5.44 
3 
735 
80.3 
5.67 
 
ED
S32421.1 
calnexin  
92.60 
7.98 
4 
589 
66.6 
4.65 
 
ED
S26585.1 
enolase  
92.12 
5.08 
2 
433 
46.6 
6.76 
 
ED
S29972.1 
A
TP synthase alpha subunit vacuolar  
91.18 
4.40 
2 
614 
68.1 
5.39 
 
ED
S42147.1 
gram
-negative bacteria binding protein  
88.09 
8.74 
3 
412 
46.7 
5.08 
 
ED
S44961.1 
m
yosin-Id  
86.80 
3.18 
2 
692 
77.9 
9.14 
 
ED
S30648.1 
arginine kinase  
77.89 
7.80 
3 
410 
45.1 
5.80 
 
A
B
C
59609.1 m
altase 1  
76.87 
4.14 
2 
580 
66.2 
5.95 
 
ED
S28502.1 
carboxylesterase-6  
75.82 
3.96 
2 
632 
71.1 
6.19 
7 
ED
S26629.1 
juvenile horm
one epoxide hydrolase 1  
206.65 
25.16 
7 
457 
51.7 
8.41 
 
ED
S42147.1 
gram
-negative bacteria binding protein  
163.44 
12.86 
5 
412 
46.7 
5.08 
 
ED
S27093.1 
trifunctional enzym
e beta subunit  
159.37 
16.49 
7 
467 
50.3 
9.01 
 
ED
S30648.1 
arginine kinase  
142.07 
15.61 
6 
410 
45.1 
5.80 
 
ED
S30010.1 
conserved hypothetical protein  
116.28 
4.19 
3 
931 
103.5 
5.02 
 
ED
S27170.1 
truncated ER
 m
annose-binding lectin  
110.70 
6.58 
3 
471 
53.4 
6.05 
 
ED
S26190.1 
adenosine diphosphatase  
110.41 
12.45 
4 
466 
51.6 
7.77 
 
ED
S26631.1 
juvenile horm
one epoxide hydrolase 1  
107.01 
7.79 
3 
462 
53.0 
6.92 
 
ED
S31071.1 
polyadenylate-binding protein 1  
85.94 
4.62 
2 
628 
69.7 
9.47 
 
ED
S26147.1 
sodium
/potassium
-transporting A
TPase alpha chain  
82.21 
4.76 
3 
735 
80.3 
5.67 
 
ED
S44431.1 
fasciclin  
71.84 
7.08 
2 
452 
48.4 
5.17 
 
ED
S27419.1 
protease m
1 zinc m
etalloprotease  
67.48 
2.57 
2 
1011 
113.2 
5.12 
8 
ED
S35272.1 
conserved hypothetical protein  - A
TP synthase alpha subunit  
2921.97 
55.90 
35 
551 
59.3 
8.94 
 
ED
S26297.1 
calcium
-transporting atpase sarcoplasm
ic/endoplasm
ic reticulum
 type  2335.41 
32.46 
4 
995 
109.1 
5.59 
 
ED
S34125.1 
conserved hypothetical protein  
2191.72 
56.65 
6 
376 
41.8 
5.48 
 
ED
S27254.1 
A
TP synthase beta subunit  
2118.71 
46.97 
19 
511 
54.6 
5.12 
 
ED
S44094.1 
actin 1  
1699.07 
48.94 
3 
376 
41.7 
5.39 
 
ED
S25844.1 
actin-2  
1689.34 
47.61 
6 
376 
41.6 
5.48 
 
ED
S30322.1 
A
TP synthase gam
m
a chain. m
itochondrial  
1211.21 
54.21 
17 
297 
32.8 
8.88 
 
ED
S29972.1 
A
TP synthase alpha subunit vacuolar  
765.00 
31.76 
17 
614 
68.1 
5.39 
 
ED
S34040.1 
fatty acid oxidation com
plex subunit alpha  
760.17 
26.34 
18 
744 
79.7 
9.06 
 
ED
S38275.1 
conserved hypothetical protein  
755.20 
34.77 
10 
302 
33.0 
9.72 
 
ED
S26604.1 
voltage-dependent anion-selective channel  
652.29 
45.39 
11 
282 
30.7 
8.56 
 
ED
S28370.1 
sodium
/potassium
-dependent A
TPase beta-2 subunit  
602.81 
34.05 
10 
326 
37.9 
6.79 
 
ED
S38514.1 
sarcalum
enin  
579.44 
13.57 
12 
958 
107.6 
3.93 
 
ED
S28367.1 
sodium
/potassium
-dependent A
TPase beta-2 subunit  
521.83 
35.65 
10 
317 
36.2 
7.64 
 
ED
S39731.1 
78 kD
a glucose-regulated protein  
520.06 
21.46 
11 
657 
72.3 
5.20 
 
ED
S30029.1 
3-dem
ethylubiquinone-9 3-m
ethyltransferase  
494.92 
30.07 
9 
306 
34.5 
6.93 
 
ED
S36550.1 
ubiquinol-cytochrom
e c reductase com
plex core protein  
493.72 
21.41 
10 
439 
45.3 
8.84 
 
ED
S40274.1 
40S ribosom
al protein S3  
484.58 
34.80 
9 
250 
27.5 
9.61 
 
ED
S30648.1 
arginine kinase  
458.40 
26.83 
13 
410 
45.1 
5.80 
 
ED
S26147.1 
sodium
/potassium
-transporting A
TPase alpha chain  
449.65 
17.41 
11 
735 
80.3 
5.67 
 
ED
S36304.1 
sodium
/potassium
-dependent A
TPase beta-2 subunit  
447.15 
24.66 
7 
292 
33.4 
6.24 
 
ED
S26512.1 
succinate dehydrogenase flavoprotein subunit. m
itochondrial  
436.97 
13.77 
7 
661 
72.1 
6.46 
 
ED
S37338.1 
short-chain dehydrogenase  
416.40 
21.52 
7 
316 
34.6 
8.13 
 
ED
S29666.1 
vacuolar A
TP synthase subunit e  
389.43 
27.88 
7 
226 
25.8 
6.81 
 
ED
S27419.1 
protease m
1 zinc m
etalloprotease  
377.47 
11.28 
10 
1011 
113.2 
5.12 
 
ED
S34105.1 
vacuolar A
TP synthase subunit ac39  
367.69 
33.05 
8 
348 
39.6 
4.94 
 
ED
S28166.1 
elongation factor 2  
349.85 
6.40 
6 
1031 
114.4 
6.71 
 
ED
S44958.1 
m
yosin heavy chain  
341.20 
1.61 
2 
1927 
219.3 
5.97 
 
ED
S34461.1 
60S ribosom
al protein L5  
314.24 
16.50 
6 
297 
34.0 
9.73 
 
ED
S32198.1 
vacuolar A
TP synthase subunit C
  
303.68 
17.99 
10 
528 
60.0 
6.13 
 
ED
S41621.1 
40S ribosom
al protein SA
  
303.08 
14.54 
3 
282 
30.8 
4.91 
 
ED
S38023.1 
bacteria responsive protein 1; A
gB
R
1  
300.66 
14.03 
5 
449 
49.2 
8.43 
 
ED
S33081.1 
60S acidic ribosom
al protein P0  
296.73 
25.08 
6 
315 
33.9 
5.81 
 
ED
S35981.1 
endoplasm
in  
291.51 
15.11 
10 
794 
91.0 
4.98 
 
ED
S41216.1 
anionic trypsin-2  
281.48 
12.12 
3 
297 
31.8 
7.88 
 
ED
S42199.1 
proliferation-associated 2g4  
280.01 
13.82 
5 
434 
46.8 
8.22 
 
A
EN
19673.1 cytochrom
e P405 C
Y
P9J40  
275.46 
15.84 
6 
524 
59.8 
8.50 
 
ED
S44784.1 
lysosom
al aspartic protease  
275.27 
19.90 
6 
387 
41.7 
5.31 
 
ED
S36212.1 
tubulin alpha-2 chain  
268.68 
9.35 
3 
449 
49.8 
5.14 
 
B
A
I77924.1 
cytochrom
e P450  
257.61 
19.76 
9 
496 
56.3 
7.69 
 
ED
S30010.1 
conserved hypothetical protein  
257.32 
6.12 
5 
931 
103.5 
5.02 
 
ED
S27170.1 
truncated ER
 m
annose-binding lectin  
253.46 
12.31 
6 
471 
53.4 
6.05 
 
ED
S42768.1 
steroid dehydrogenase  
243.73 
16.30 
4 
319 
34.7 
9.50 
 
ED
S34510.1 
cytochrom
e P450 9b2  
242.12 
8.24 
4 
534 
61.3 
7.90 
 
ED
S42147.1 
gram
-negative bacteria binding protein  
235.12 
13.59 
5 
412 
46.7 
5.08 
 
ED
S45475.1 
conserved hypothetical protein  
225.43 
20.78 
6 
332 
35.4 
8.25 
 
ED
S32263.1 
serine-type enodpeptidase  
224.32 
19.59 
3 
296 
32.0 
5.02 
 
ED
S32138.1 
heat shock 70 kD
a protein cognate 4  
218.49 
10.53 
4 
655 
71.4 
5.52 
 
ED
S30841.1 
conserved hypothetical protein  
216.54 
9.31 
6 
462 
52.9 
5.24 
 
ED
S33630.1 
zinc carboxypeptidase A
 1  
193.62 
14.65 
4 
430 
48.9 
5.19 
 
ED
S38373.1 
activated protein kinase C
 receptor  
189.62 
28.30 
9 
311 
34.9 
7.88 
 
ED
S38397.1 
soluble N
SF attachm
ent protein  
177.44 
17.75 
5 
293 
33.0 
5.85 
 
ED
S28502.1 
carboxylesterase-6  
177.38 
5.06 
3 
632 
71.1 
6.19 
 
ED
S44930.1 
l(2) long form
  
165.06 
3.79 
4 
1294 
148.8 
4.58 
 
ED
S26618.1 
prohibitin-2  
164.97 
15.38 
5 
299 
33.1 
9.67 
 
ED
S39442.1 
V
-type A
TP synthase beta chain  
162.82 
9.15 
4 
492 
54.7 
5.49 
 
ED
S35346.1 
m
em
brane associated progesterone receptor  
153.54 
23.25 
4 
228 
24.3 
4.83 
 
ED
S31006.1 
am
inopeptidase N
  
152.31 
2.21 
4 
1852 
210.0 
5.08 
 
ED
S37258.1 
cytochrom
e P450 9b1  
152.07 
6.55 
2 
534 
61.0 
7.78 
 
ED
S33477.1 
phosphatidylinositol transfer protein/retinal degeneration b protein  
151.83 
24.07 
5 
270 
31.1 
6.44 
 
ED
S34661.1 
zinc carboxypeptidase  
151.47 
6.78 
2 
428 
48.8 
5.10 
 
B
0W
N
96.2 
R
ecN
am
e: Full=40S ribosom
al protein S3a 
150.45 
15.56 
3 
270 
30.0 
9.42 
 
ED
S35048.1 
conserved hypothetical protein  
147.19 
12.25 
6 
645 
71.4 
6.86 
 
ED
S40443.1 
m
itochondrial cytochrom
e c1  
146.62 
18.30 
4 
306 
33.2 
8.94 
 
ED
S39919.1 
disulfide isom
erase  
145.56 
6.29 
3 
493 
55.4 
4.91 
 
ED
S31640.1 
conserved hypothetical protein  
145.27 
20.90 
5 
244 
26.7 
6.65 
 
ED
S37912.1 
U
D
P-glucuronosyltransferase 2C
1  
131.65 
9.63 
4 
509 
56.9 
8.79 
 
ED
S35706.1 
vacuolar A
TP synthase subunit H
  
126.53 
8.44 
3 
474 
54.5 
6.14 
 
ED
S27414.1 
palm
itoyl-protein thioesterase 1  
126.32 
8.70 
2 
299 
34.0 
6.39 
 
ED
S38951.1 
alpha-glucosidase  
121.69 
8.93 
5 
605 
69.4 
5.20 
 
ED
S33030.1 
cytochrom
e P450 4g15  
120.09 
4.42 
4 
566 
64.6 
8.53 
 
ED
S33238.1 
fructose-bisphosphate aldolase  
118.87 
7.99 
3 
363 
39.2 
7.62 
 
ED
S44707.1 
cytochrom
e P450 93A
3  
118.01 
10.02 
5 
499 
57.6 
8.50 
 
ED
S34505.1 
cytochrom
e P450 52A
5  
117.92 
8.52 
3 
540 
62.0 
7.44 
 
ED
S34537.1 
cytochrom
e P450 12b1. m
itochondrial  
112.63 
7.43 
4 
525 
60.0 
7.74 
 
ED
S37463.1 
polyserase-2  
111.44 
8.14 
3 
381 
40.2 
8.10 
 
ED
S43476.1 
glycogen phosphorylase  
103.80 
5.46 
5 
842 
96.6 
6.37 
 
ED
S25938.1 
succinate dehydrogenase  
101.44 
10.56 
3 
303 
34.1 
7.50 
 
ED
S28607.1 
lipase  
98.30 
10.72 
2 
345 
37.4 
6.76 
 
ED
S34662.1 
carboxypeptidase A
1  
96.08 
9.18 
3 
425 
48.4 
5.19 
 
ED
S36767.1 
C
D
98hc am
ino acid transporter protein  
95.47 
3.29 
2 
639 
70.2 
5.08 
 
ED
S44578.1 
m
otor-protein  
94.33 
3.51 
3 
769 
85.2 
8.85 
 
B
0W
Y
Y
2.1 
R
ecN
am
e: Full=M
oesin/ezrin/radixin hom
olog 1 
93.26 
3.32 
2 
572 
67.7 
5.68 
 
ED
S35443.1 
60S ribosom
al protein L14  
90.05 
13.41 
2 
179 
20.7 
11.15 
 
ED
S44962.1 
m
yosin heavy chain  
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Supplementary Fig. 1. Homologous competition binding assays between labeled (125I-) 
Cry48Aa, or Cry49Aa, or a mixture of both toxins (10 nM) with midgut brush border 
membrane fractions (25 µg) from Culex quinquefasciatus larvae in the absence, or in 
the presence, of the respective unlabeled toxins (3-3000 nM). Maximum binding 
corresponds to the binding observed in the absence of competitor. The competitor 
concentration that displaces 50% of the 125I-bound toxin (IC50) is indicated. Each point 
is the mean of, at least, four experimental replicates.  
 
Figure supplementary 1
 Supplementary Fig. 2. Pull-down assay to evaluate the binding of the recombinant 
Cqm1 protein to the recombinant Cry48Aa/Cry49Aa-GST toxin (A), BinB-GST toxin 
(B) or GST (C, negative control) immobilized on sepharose beads. After incubation, 
beads were washed and bound proteins were separated on 10% SDS-PAGE, transferred 
to nitrocellulose membranes and subjected to immunodetection with an antibody raised 
against Cqm1 protein. P. Cqm1 protein (0.15 µg). MW molecular weight in kDa. 
 
 
Figure supplementary 2
